Cargando…

Pott’s Disease Caused by Mycobacterium bovis Following Intravesical BCG Therapy for Bladder Cancer

BACKGROUND: Bacillus Calmette-Guerin (BCG) are attenuated strains of Mycobacterium bovis, which is part of the Mycobacterium tuberculosis complex. BCG is used for bladder cancer therapy. CASE/METHODS: 80 year old man presented with severe back pain, paraplegia, urine retention. Past history included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Zachary, Fazili, Tasaduq, Eranki, Ambika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631136/ http://dx.doi.org/10.1093/ofid/ofx163.1807

Ejemplares similares

704 Mycobacterium bovis vertebral osteomyelitis due to intravesical Bacillus Calmette-Guérin (BCG): A rare complication of a common therapy
por: Sharngoe, Calden, et al.
Publicado: (2014)

Pott's disease post intravesical BCG
por: Jain, Anika
Publicado: (2023)

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer
por: Seegobin, Karan, et al.
Publicado: (2017)

Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
por: Elzein, Fatehi, et al.
Publicado: (2016)

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette–Guérin (BCG) immunotherapy
por: Meyer, Ryan K., et al.
Publicado: (2020)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
por: Gomez, Eric, et al.
Publicado: (2009)

Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer
por: Mackel, Charles E, et al.
Publicado: (2016)

Infected Aortic Aneurysm caused by Mycobacterium bovis after Intravesical Bacillus Calmette-Guérin Treatment for Bladder Cancer
por: Nam, Eun Young, et al.
Publicado: (2015)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

Mycobacterium bovis BCG osteoarticular infection complicating immune therapy for bladder cancer: a case report
por: Stern, Rebecca, et al.
Publicado: (2021)

Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette–Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus
por: DeSimone, Daniel C., et al.
Publicado: (2016)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Successful endovascular exclusion of Mycobacterium bovis mycotic aneurysm following intravesical bacille Calmette–Guerin therapy
por: Cook, Victoria, et al.
Publicado: (2022)

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG
Publicado: (2015)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
por: Arsuffi, Stefania, et al.
Publicado: (2023)

Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)

Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival
por: Pascoe, Jordan, et al.
Publicado: (2020)

Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
por: Quatannens, Frédéric, et al.
Publicado: (2022)

Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature
por: Oladiran, Oreoluwa, et al.
Publicado: (2020)

A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
por: Itai, Mariko, et al.
Publicado: (2021)

Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
por: Ludannyy, R., et al.
Publicado: (2015)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
por: Espinosa-Cueto, Patricia, et al.
Publicado: (2020)

BCG vaccine: Disseminated Mycobacterium bovis infection: case report
Publicado: (2021)

1764. Use of Intravesical BCG for Treatment of Bladder Cancer in a Renal Transplant Recipient, with Subsequent Resolution of Chronic BK Viremia
por: Kit Chan, Yu, et al.
Publicado: (2019)

An uncommon cause of miliary disease: intravesical BCG immunotherapy
por: Azevedo, Marcelo, et al.
Publicado: (2021)

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
por: Berrêdo-Pinho, Marcia, et al.
Publicado: (2011)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin
por: Samannodi, Mohammed, et al.
Publicado: (2018)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma
por: Doroud, Delaram, et al.
Publicado: (2022)

Complete Genome Sequence of Mycobacterium bovis BCG SL222 Sofia, the First WHO Reference Reagent for the M. bovis BCG Vaccine of the Russian BCG-I Substrain
por: Panaiotov, Stefan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_curkn4ctd1rnvhdc2o7tvokdds